4-hydroxy-25-desoxyneorollinicin has been researched along with colforsin in 1 studies
Studies (4-hydroxy-25-desoxyneorollinicin) | Trials (4-hydroxy-25-desoxyneorollinicin) | Recent Studies (post-2010) (4-hydroxy-25-desoxyneorollinicin) | Studies (colforsin) | Trials (colforsin) | Recent Studies (post-2010) (colforsin) |
---|---|---|---|---|---|
62 | 0 | 7 | 13,460 | 46 | 1,298 |
Protein | Taxonomy | 4-hydroxy-25-desoxyneorollinicin (IC50) | colforsin (IC50) |
---|---|---|---|
nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 1.729 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.041 | |
Adenylate cyclase type 1 | Homo sapiens (human) | 0.0955 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chih, TT; Chiu, HF; Hsian, YM; Tseng, CH; Wu, MJ; Wu, YC | 1 |
1 other study(ies) available for 4-hydroxy-25-desoxyneorollinicin and colforsin
Article | Year |
---|---|
Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Colforsin; Cyclic AMP; Cyclic GMP; Drug Interactions; Fluorescein-5-isothiocyanate; Furans; Humans; S-Nitrosoglutathione; Tumor Cells, Cultured | 2003 |